Fluvoxamine

Alternative Names: Luvox

Fluvoxamine is an antidepressant (SSRI) that has shown promising early evidence for treating long COVID, particularly fatigue. A 2026 randomized controlled trial in nearly 400 patients found that people taking fluvoxamine had meaningful reductions in fatigue and improved quality of life over 2–3 months, making it the strongest psychiatric medication evidence so far for established long COVID symptoms. These benefits are thought to come from its anti-inflammatory effects and action on the sigma-1 receptor, which may help regulate immune and stress responses.

Treatment Type: Prescription Medication

Treatment Class: SSRI

Treatment Modality: Oral

Fluvoxamine

Review Summary

4.0

1 Reviews

Preferred by 1 Reviewers

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
5.0
1 = Very Expensive 5 = Very Affordable

5.0

Very Affordable
Relief Speed
2.0
1 = No Relief 5 = Immediate Relief

2.0

Slow Relief
Side Effects
4.0
1 = Intolerable Effect 5 = No Effect

4.0

Mild Effect
Treatment Line
5.0
1 = Third-line or more 5 = First-line

5.0

First-line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

4.0

1 Reviews
5
0%
4
100%
3
0%
2
0%
1
0%

Reviews

Filter by reviewer type Pro

Select all Clear all

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
1 day ago
Fluvoxamine has some of the stronger emerging evidence for Long COVID fatigue. A 2026 randomized trial found that fluvoxamine 100 mg twice daily modestly improved fatigue and quality of life compared with placebo, with benefits still present at 90 days. This was the first adequately powered study to directly evaluate fluvoxamine for established Long COVID rather than acute COVID infection. Current Long COVID guidance also lists fluvoxamine as a medication under investigation for brain fog and cognitive symptoms.
#VeryAffordable #SlowRelief #MildEffect #First-line
View Professional Disclosures

Copyright © 2025,Curbside and related marks are registered trademarks of Curbside Tech Inc.

We use cookies to personalize our services and provide you with the best possible experience. By continuing to use this site, you agree to this cookie usage. We also use third-party cookies that help us analyse how you use this website, store your preferences, and provide the content and advertisements that are relevant to you. These cookies will only be stored in your browser with your prior consent. You can learn more about cookies and how your data is processed in the Privacy Policy.

Strictly Necessary Only Accept All